These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 460862)

  • 21. Current concepts of somatomedin and other biologically related growth factors.
    Chochinov RH; Daughaday WH
    Diabetes; 1976 Oct; 25(10):994-1004. PubMed ID: 185112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endocrine dwarfism. 2. Treatment of hypothalamo-hypophyseal dwarfism and of constitutional dwarfism with postponement of puberty].
    Hesse V
    Kinderarztl Prax; 1975 Apr; 43(4):180-5. PubMed ID: 772271
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of the administration of human growth hormone on L-proline tolerance in pituitary dwarfism].
    Florea I; Popa M; Ionescu V; Dinulescu E; Ganea E
    Stud Cercet Endocrinol; 1971; 22(6):455-8. PubMed ID: 5135422
    [No Abstract]   [Full Text] [Related]  

  • 24. [Growth hormone deficiency dwarfism and idiopathic hypopituitarism. Study of hypothalamo-hypophyseal function].
    Martín Zurro A; Sánchez Franco F; Cerdán Vallejo A; García García MD; Cacicedo L
    Rev Clin Esp; 1973 Jul; 130(2):117-22. PubMed ID: 4582541
    [No Abstract]   [Full Text] [Related]  

  • 25. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary hydroxyproline and circulating HGH. (Preliminary findings in some endocrine diseases)].
    Recchia O; Sereno L; Isidori A
    Folia Endocrinol; 1967 Aug; 20(4):420-41. PubMed ID: 5631031
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of endocrine diseases in childhood and adolescence. 4: Hypophyseal dwarfism].
    Butenandt O
    Fortschr Med; 1984 Sep; 102(34):838-40. PubMed ID: 6436153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Group discussion: on the 2d International Symposium on Growth Hormone].
    Shizume K; Irie M; Matsuzaki S; Sawano S
    Horumon To Rinsho; 1971 Dec; 19(12):971-87. PubMed ID: 4400627
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secretion of corticotropin and somatotropin during the insulin test in partial hypopituitarism].
    Materazzi F; Rolla M; Menchini GF; Pennisi F
    Folia Endocrinol; 1971; 24(3):331-9. PubMed ID: 4332743
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly.
    Rovenský J; Vigas M; Lokaj J; Cuncík P; Lukác P; Takác A
    Endocrinol Exp; 1982 Jun; 16(2):129-34. PubMed ID: 6980785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth hormone and insulin-like growth factor in the dog: clinical and experimental studies].
    Eigenmann JE
    Schweiz Arch Tierheilkd; 1986 Feb; 128(2):57-78. PubMed ID: 3704613
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of growth-hormone secretion in health and disease.
    Lancet; 1969 Jan; 1(7585):85-6. PubMed ID: 4178006
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of somatostatin in patients with high plasma growth hormone].
    Pertzelan A; Doron M; Assa S; Keret R; Laron Z
    Harefuah; 1977 Aug; 93(3-4):74-6. PubMed ID: 914113
    [No Abstract]   [Full Text] [Related]  

  • 34. [Editorial: Growth hormone].
    Prange-Hansen A
    Ugeskr Laeger; 1974 May; 136(19):1038-9. PubMed ID: 4827789
    [No Abstract]   [Full Text] [Related]  

  • 35. [Some interrelations between the somatropic pituitary hormone (STG) and sex hormone derivatives in the regulation of protein metabolism].
    Balabolkin MI; Gasanov SG
    Vrach Delo; 1972 Jan; 1():113-4. PubMed ID: 5017187
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reserve capacity of hypophyseal trophic hormones. Plasma ACTH levels and ACTH reserve in adrenal cortex diseases].
    János J; Tamás J; Ferenc L; Mihály K; Ferenc L
    Orv Hetil; 1981 Mar; 122(9):495-9. PubMed ID: 6270611
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism.
    Costom BH; Grumbach MM; Kaplan SL
    J Clin Invest; 1971 Oct; 50(10):2219-25. PubMed ID: 4330007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological explorations in pituitary dwarfism in children].
    Weill J
    Lille Med; 1980 May; 25(5):218-23. PubMed ID: 7392772
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular aspects of hereditary growth hormone defects].
    Argente Oliver J
    An Esp Pediatr; 1990 Nov; 33 Suppl 42():132-8. PubMed ID: 2097918
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of human growth hormone on different tests for functional exploration of carbohydrate metabolism in pituitary dwarfs].
    Elsair J; Royer P
    J Physiol (Paris); 1969; 61(3):169-83. PubMed ID: 4933602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.